Journal
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
Volume 25, Issue 7, Pages 1561-1569Publisher
ELSEVIER
DOI: 10.1016/j.jstrokecerebrovasdis.2016.03.052
Keywords
VZV; vasculopathy; stroke; giant cell arteritis
Categories
Funding
- National Institutes of Health [AG032958]
Ask authors/readers for more resources
Background: Varicella zoster virus (VZV) is a neurotropic, exclusively human herpesvirus. Primary infection causes varicella (chickenpox), after which the virus becomes latent in ganglionic neurons along the entire neuraxis. As cell-mediated immunity to VZV declines with advancing age and immunosuppression, VZV reactivates to produce zoster (shingles). One of the most serious complications of zoster is VZV vasculopathy. Methods: We reviewed recent studies of stroke associated with varicella and zoster, how VZV vasculopathy is verified virologically, vaccination to prevent varicella and immunization to prevent zoster, and VZV in giant cell arteritis (GCA). Findings: We report recent epidemiological studies revealing an increased risk of stroke after zoster; the clinical, laboratory, and imaging features of VZV vasculopathy; that VZV vasculopathy is confirmed by the presence of either VZV DNA or anti-VZV IgG antibody in cerebrospinal fluid; special features of VZV vasculopathy in children; vaccination to prevent varicella and immunization to prevent zoster; and the latest evidence linking VZV to GCA. Conclusion: In children and adults, VZV is a common cause of stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available